充血性心力衰竭 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week
Left Ventricular Assist Devices: Synergistic Model Between Technology and Medicine
Vaccination Trends in Patients With Heart Failure - Insights From Get With The Guidelines–Heart Failure
Antithrombotics From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5)
Ejection Fraction Pros and Cons: JACC State-of-the-Art Review
Heart Failure With Preserved Ejection Fraction in the Young
Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure

|<< 1 2 3 4 5 6 7 ...>>|

Review Article

2018;138:2841–2851

JOURNAL：Circulation.

Article Link

Left Ventricular Assist Devices: Synergistic Model Between Technology and Medicine

JJ Han, MA Acker, P Atluri et al.

5574

Keywords: left ventricular assist device; heart failure; suck-down event; park stitch; HMIII artificial pulsatility; hemocompatability; quality-adjusted life years; incremental cost-effectiveness ratio

FULL TEXT PDF